Johnson & Johnson

J&J starts human safety trial for its COVID-19 vaccine candidate

J&J working on COVID-19 vaccine deals with Japan and Gates Foundation

Johnson & Johnson raises forecast after quarterly profit beats estimates

Missouri court upholds verdict in Johnson & Johnson talc case but reduces damages to $2.1-billion

European Commission in advanced talks with Johnson & Johnson on COVID-19 vaccine deal, sources say

Johnson & Johnson moves up start of coronavirus vaccine human trials to July

Chanel, Revlon, L’Oreal pivoting away from talc in some products

Johnson & Johnson to stop selling talc-based baby powder in Canada and U.S.

U.S. judge rules talc lawsuits against J&J can proceed, testimony limited

The Globe’s stars and dogs for the week

Evening Update: Ottawa, provinces in talks to reopen economy in stages; Trudeau and Scheer face criticism over travel

Johnson & Johnson sees recovery in coronavirus-hit medical devices unit at end of year

Johnson & Johnson aims to begin testing of coronavirus vaccine by September, plans to manufacture 1 billion doses

Johnson & Johnson ramps up Tylenol production as demand surges

Apple, J&J to study if Apple Watch can help reduce stroke risk

Johnson & Johnson ordered to pay US$344-million in pelvic mesh case